Globus Medical director sells stock as Cardinal Health sees growth

Globus Medical Director Stephen Zarrilli sold 25,000 shares of the company on August 18th at an average price of $87.04, totaling approximately $2,176,000. This transaction reduced his position in the firm by 50%.

Separately, Cardinal Health is seeing revenue growth driven by its Pharmaceutical and Specialty Solutions segment. The segment reported $234.8 billion in FY2026 revenues, a 15% year-over-year increase. The company is positioning itself to capitalize on the precision medicine market, which is projected to grow at a 17% compound annual growth rate.